GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for ...

GLP-1s - which mimic the effects of the hormone that stimulates insulin release, suppressing glucagon, and slowing gastric emptying - also have a range of other benefits.

Formerly known as juvenile diabetes, type 1 diabetes can develop at any age. Learn how it progresses differently among children and adults and what screening options exist.

Vertex Pharmaceuticals' new therapy, zimislecel, has potential to be a "functional cure," experts say. To continue reading and help Philly news thrive, unlock this exclusive offer for unlimited ...

In today's Morning Rounds newsletter: a failed long Covid drug may get another shot, the benefits of even a little activity ...

More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...

Mady Debenedetto, a 14-year-old from Cranston, recently represented Rhode Island at the Breakthrough T1D Congress in ...

Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...

Danegaptide, a potential oral therapy for nonproliferative diabetic retinopathy, is advancing to a phase 2 trial after ...

No one should feel 50 in their 30s. With the right awareness, systems, and support, it’s possible to change the ...

An international team of researchers has made a key discovery: many children and young adults in Sub-Saharan Africa diagnosed with type 1 diabetes (T1D) may have a different form of the disease—one ...